Our September sale is now live until 30th September 2021! Apply a 15% discount to your cart in Store using promotional code: EQLYSEP21

Takeda Pharmaceutical Co Ltd in Consumer Health

April 2013

Takeda Pharmaceutical Co Ltd, a Japan-based producer of prescription and consumer health products, is spreading its wings. Historically dependent on Japan for sales (in 2007, the market generated 96% of its consumer health values), a series of acquisitions in 2011 and 2012 has seen it push into new emerging markets in Eastern Europe, Latin America, Asia Pacific and Western Europe. Further acquisitions seem likely, as the company has substantial cash reserves, and like many of its Japanese peers

USD 570
Request More Information

Delivery

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

Overview:

Euromonitor International's report on Takeda Pharmaceutical Co Ltd delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Takeda Pharmaceutical Co Ltd, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Takeda Pharmaceutical Co Ltd.

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Takeda Pharmaceutical Co Ltd provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Introduction

Scope

Strategic Evaluation

Key company facts
Mature Japanese market still a solid base for Takeda
Evolving retailing landscapes offer new opportunities
Strategic shift set to affect profitability
SWOT: Takeda Pharmaceutical Co Ltd

Competitive Positioning

Acquisitions drive Takeda switch from local to global player
Japanese firms eyeing expansion through acquisition
Acquisitions offer easy growth in new categories and markets

Market Assessment

Acquisition strategy has reweighted portfolio
Acquisitions help reverse negative VDS trend
Analgesics
Digestive remedies
Despite takeovers, Japan still dominates Asia Pacific operations
Western European scale comes at a price

Geographic and Category Opportunities

New markets to drive sales for Takeda
OTC in Brazil: Takeda’s golden opportunity
Russia provides launching pad for Eastern Europe
Looking back to VDS could provide a brighter future

Brand Strategy

Alinamin could see international push
Neosaldina

Operations

Company overview
Takeda: Leading consumer health brands
Research and development

Recommendations

Key takeaways
Share:

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page